Cargando…

Two predictive precision medicine tools for hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is a serious threat to public health due to its poor prognosis. The current study aimed to develop and validate a prognostic nomogram to predict the overall survival of HCC patients. METHODS: The model cohort consisted of 24,991 mRNA expression data points...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhiqiao, Li, Jing, He, Tingshan, Ouyang, Yanling, Huang, Yiyan, Liu, Qingbo, Wang, Peng, Ding, Jianqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6854692/ https://www.ncbi.nlm.nih.gov/pubmed/31754347 http://dx.doi.org/10.1186/s12935-019-1002-z

Ejemplares similares

Comprehensive bioinformatics analysis reveals potential lncRNA biomarkers for overall survival in patients with hepatocellular carcinoma: an on-line individual risk calculator based on TCGA cohort
por: Zhang, Zhiqiao, et al.
Publicado: (2019)

Two precision medicine predictive tools for six malignant solid tumors: from gene-based research to clinical application
por: Zhang, Zhiqiao, et al.
Publicado: (2019)

The competitive endogenous RNA regulatory network reveals potential prognostic biomarkers for overall survival in hepatocellular carcinoma
por: Zhang, Zhiqiao, et al.
Publicado: (2019)

Development and internal validation of a nine-lncRNA prognostic signature for prediction of overall survival in colorectal cancer patients
por: Zhang, Zhiqiao, et al.
Publicado: (2018)

Nomogram for cirrhosis in patients with chronic hepatitis B: A simple self-assessed scale for individual risk of cirrhosis
por: Zhang, Zhiqiao, et al.
Publicado: (2017)

FibroScan Detection of Fatty Liver/Liver Fibrosis in 2266 Cases of Chronic Hepatitis B
por: He, Tingshan, et al.
Publicado: (2020)

Bioinformatics Identified 17 Immune Genes as Prognostic Biomarkers for Breast Cancer: Application Study Based on Artificial Intelligence Algorithms
por: Zhang, Zhiqiao, et al.
Publicado: (2020)

Artificial intelligence predictive system of individual survival rate for lung adenocarcinoma
por: He, Tingshan, et al.
Publicado: (2022)

Multilevel regulation of RUVBL2 expression predicts poor prognosis in hepatocellular carcinoma
por: Yan, Tao, et al.
Publicado: (2019)

A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma
por: Ouyang, Guoqing, et al.
Publicado: (2020)

Immune gene prognostic signature for disease free survival of gastric cancer: Translational research of an artificial intelligence survival predictive system
por: Zhang, Zhiqiao, et al.
Publicado: (2021)

Potential Prognostic Immune Biomarkers of Overall Survival in Ovarian Cancer Through Comprehensive Bioinformatics Analysis: A Novel Artificial Intelligence Survival Prediction System
por: He, Tingshan, et al.
Publicado: (2021)

Differences of survival benefits brought by various treatments in ovarian cancer patients with different tumor stages
por: He, Tingshan, et al.
Publicado: (2023)

Improve individual treatment by comparing treatment benefits: cancer artificial intelligence survival analysis system for cervical carcinoma
por: Liang, Jieyi, et al.
Publicado: (2022)

TRAIL promotes hepatocellular carcinoma apoptosis and inhibits proliferation and migration via interacting with IER3
por: Liu, Shihai, et al.
Publicado: (2021)

Expression and diagnostic value of CCT3 and IQGAP3 in hepatocellular carcinoma
por: Qian, E-Na, et al.
Publicado: (2016)

Competing endogenous RNA network identifies mRNA biomarkers for overall survival of lung adenocarcinoma: two novel on-line precision medicine predictive tools
por: Lin, Jinsong, et al.
Publicado: (2021)

LPCAT1 overexpression promotes the progression of hepatocellular carcinoma
por: He, Rong-Quan, et al.
Publicado: (2021)

DNA methylation biomarkers for hepatocellular carcinoma
por: Fan, Guorun, et al.
Publicado: (2018)

UBE2I promotes metastasis and correlates with poor prognosis in hepatocellular carcinoma
por: Yang, Hao, et al.
Publicado: (2020)

Efficacy and safety of lenvatinib monotreatment and lenvatinib-based combination therapy for patients with unresectable hepatocellular carcinoma: a retrospective, real-world study in China
por: Zhu, Yun, et al.
Publicado: (2021)

Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma
por: Liu, Gao-Min, et al.
Publicado: (2019)

Random-forest algorithm based biomarkers in predicting prognosis in the patients with hepatocellular carcinoma
por: Guo, Lingyun, et al.
Publicado: (2020)

Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma
por: Peng, Yanan, et al.
Publicado: (2021)

ADAM17 promotes the invasion of hepatocellular carcinoma via upregulation MMP21
por: Xiang, Yuqi, et al.
Publicado: (2020)

Integrated nomogram based on five stage-related genes and TNM stage to predict 1-year recurrence in hepatocellular carcinoma
por: Liu, Haohan, et al.
Publicado: (2020)

Precision medicine for hepatocellular carcinoma: driver mutations and targeted therapy
por: Ding, Xiao-Xiao, et al.
Publicado: (2017)

Tumor-associated macrophages modulate resistance to oxaliplatin via inducing autophagy in hepatocellular carcinoma
por: Fu, Xiu-Tao, et al.
Publicado: (2019)

NONO promotes hepatocellular carcinoma progression by enhancing fatty acids biosynthesis through interacting with ACLY mRNA
por: Ding, Hongda, et al.
Publicado: (2020)

Integrated analysis reveals potential long non-coding RNA biomarkers and their potential biological functions for disease free survival in gastric cancer patients
por: Cheng, Canchang, et al.
Publicado: (2019)

FOXC2 is a prognostic biomarker and contributes to the growth and invasion of human hepatocellular carcinoma
por: Chen, Jinzhang, et al.
Publicado: (2020)

An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients
por: Zhu, Gongmin, et al.
Publicado: (2021)

A novel qualitative signature based on lncRNA pairs for prognosis prediction in hepatocellular carcinoma
por: Bu, Xiaoyun, et al.
Publicado: (2022)

A novel prognostic model based on single-cell RNA sequencing data for hepatocellular carcinoma
por: Lu, Juan, et al.
Publicado: (2022)

Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance
por: Levin, May, et al.
Publicado: (2021)

Decrease expression of microRNA-744 promotes cell proliferation by targeting c-Myc in human hepatocellular carcinoma
por: Lin, Feng, et al.
Publicado: (2014)

Ring finger protein 152-dependent degradation of TSPAN12 suppresses hepatocellular carcinoma progression
por: Wan, Jian, et al.
Publicado: (2021)

Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

The expression profiles and prognostic values of HSP70s in hepatocellular carcinoma
por: Wang, Ben, et al.
Publicado: (2021)

Knockdown of POLQ interferes the development and progression of hepatocellular carcinoma through regulating cell proliferation, apoptosis and migration
por: Pan, Qi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m2o0d603ma0c6hu0sg846tb3gj